ZTS, US98978V1035

Jefferies cuts target for Zoetis stock from USD 103 to USD 83

Published on 10/27/2026 at 13:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The target cut came on October 20, 2026 as pricing pressure challenged growth. Zoetis stock costs EUR 72.29 on October 27, 2026 versus EUR 71.88 at Frankfurt.

Results dividend and valuation

  • Jefferies cut its Zoetis target from USD 103.00 to USD 83.00 on October 20, 2026.
  • Second-quarter revenue reached USD 2.47 billion for the period ended June 30, 2026.
  • Zoetis stock traded at EUR 72.29 at 1:49 p.m. CET at Lang & Schwarz on October 27, 2026.
ZTS, US98978V1035, Illustration mit AI erstellt.

Zoetis (ISIN US98978V1035) faced a USD 20.00 reduction in Jefferies' price target, from USD 103.00 to USD 83.00 on October 20, 2026, according to Investing.com. Jefferies also moved its rating from Buy to Hold as pricing pressure challenged the animal-health company's growth outlook.

Pricing pressure meets weak demand

The downgrade followed Zoetis' second-quarter performance for the period ended June 30, 2026. Revenue was USD 2.47 billion, down 0.20 percent from the prior-year quarter, while net income attributable to common shareholders was USD 691.00 million, according to the quarterly financial data.

Zoetis' operating margin was 37.00 percent in the second quarter of 2026, compared with 35.00 percent in the first quarter of 2026. The result shows why the debate has shifted from headline profitability to the durability of pricing and volume.

What does the target cut mean?

Jefferies' case centers on lower pricing power and volume constraints. Its USD 83.00 target is USD 20.00 below the previous USD 103.00 target, a 19.42 percent reduction calculated from the old target. The firm said pricing had contributed 64.00 percent of Zoetis' earnings-per-share growth from 2022 through 2025, according to Investing.com.

Three dated signals for ZTS

On August 6, 2026, Zoetis reported second-quarter revenue of USD 2.47 billion and diluted earnings per share of USD 1.65, as summarized by Benzinga. On October 8, 2026, Zoetis declared a fourth-quarter dividend of USD 0.53 per share, according to the SEC. On October 20, 2026, Jefferies cut its target to USD 83.00 from USD 103.00.

Two dates ahead

October 30, 2026 is the record date for the USD 0.53 dividend, according to Zoetis. The company is scheduled to report third-quarter 2026 results on November 5, 2026, before the US market opens, according to The Earnings Madness.

Valuation and the next report

Zoetis had a market capitalization of USD 33.5 billion as of October 26, 2026. Its primary listing is on the New York Stock Exchange, and its 52-week range was USD 68.77 to USD 147.93 on that date. The next report will test whether livestock and diagnostics can offset pressure in companion-animal products.

Trading in Germany

At Lang & Schwarz, Zoetis stock was trading at EUR 72.29 on October 27, 2026 at 1:49 p.m. CET. The Frankfurt indication stood at EUR 71.88 at 9:55 p.m. CET on October 26, 2026. The further course of trading is shown by the continuously updated real-time quote of ZTS stock.

Zoetis stock at a glance

  • Company: Zoetis Inc.
  • ISIN: US98978V1035
  • Ticker: ZTS
  • Primary exchange: New York Stock Exchange
  • Price Lang & Schwarz (as of October 27, 2026, 1:49 p.m. CET): EUR 72.29
  • Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
  • Index membership: S&P 500
  • Market capitalization: USD 33.5 billion (as of October 26, 2026)
  • 52-week range: USD 68.77-147.93 (as of October 26, 2026)

Market context: Market report S&P 500.

More news and analyses on ZTS stock

Disclaimer...
en | US98978V1035 | ZTS | boerse | 70420537 |